OTC:INLB Item 9 Labs (INLB) Stock Price, News & Analysis → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free INLB Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume16.93 million shsMarket Capitalization$70,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Item 9 Labs alerts: Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About Item 9 Labs Stock (OTC:INLB)Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.Read More Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy INLB Stock News HeadlinesJanuary 4, 2024 | morningstar.comItem 9 Labs CorpDecember 19, 2023 | finance.yahoo.comItem 9 Labs Corp. Retains Sharp Capital Advisors to Facilitate a Sale of the BusinessApril 25, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.August 11, 2023 | markets.businessinsider.com'The Jewel In The Crown': How Data Is Shaping Cannabis Retail, 'Customers Are Key', Says Item 9 Labs CEOAugust 9, 2023 | seekingalpha.comINLB Item 9 Labs Corp.August 3, 2023 | benzinga.com'We're Owned By People From The Community," Says Item 9 Labs Corp CEO On Its Franchise ModelMay 23, 2023 | msn.comItem 9 Labs announces restructuring to cut costsMay 23, 2023 | finance.yahoo.comItem 9 Labs Corp. Executes Major Restructuring to Pave the Way to ProfitabilityApril 25, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.May 10, 2023 | finance.yahoo.comItem 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-RollsApril 13, 2023 | finance.yahoo.comUnity Rd. To Exhibit at 2023 Multi-Unit Franchising ConferenceApril 6, 2023 | finance.yahoo.comItem 9 Labs Corp. To Present at the Benzinga Spring Cannabis Capital ConferenceApril 5, 2023 | benzinga.comItem 9 Labs Stock (OTC:INLB), Earnings Estimates, EPS, and RevenueMarch 31, 2023 | stockhouse.comItem 9 Labs Corp. CEO Mike Weinberger Appointed To National Cannabis Industry Association's Retail CommitteeMarch 29, 2023 | finance.yahoo.comItem 9 Labs Corp. CEO Mike Weinberger Appointed To National Cannabis Industry Association’s Retail CommitteeMarch 22, 2023 | msn.comItem 9 Labs February Unit Sales Grow 30% YOYMarch 22, 2023 | finance.yahoo.comItem 9 Labs Continues Dominating the Arizona Market With a 30% YOY Unit Sales Increase in FebruaryMarch 9, 2023 | finance.yahoo.comUnity Rd. Signs First Agreement For Future Cannabis Establishment in the Green Mountain StateMarch 1, 2023 | msn.comItem 9 Labs Corp. Receives Recognition As One Of Best Cannabis Company To Work ForFebruary 28, 2023 | finance.yahoo.comItem 9 Labs Corp. Honored as a 2023 "Best Cannabis Company to Work For" by Cannabis Business TimesFebruary 23, 2023 | finance.yahoo.comUnity Rd. Awarded Full License Approval for New Denver DispensaryFebruary 17, 2023 | markets.businessinsider.comNoble Financial Keeps Their Hold Rating on Item 9 Labs (INLB)February 15, 2023 | benzinga.comItem 9 Labs Secures Financing To Complete Acquisition Of Sessions Cannabis In March 2023February 15, 2023 | finance.yahoo.comItem 9 Labs Corp. Secures Financing to Complete Acquisition of Sessions Cannabis in March 2023February 8, 2023 | finance.yahoo.comItem 9 Labs Generates 30% YOY Increase in Units Sold in JanuaryJanuary 12, 2023 | finance.yahoo.comItem 9 Labs Closes Out 2022 as a Top 10 Cannabis Brand in ArizonaDecember 16, 2022 | finance.yahoo.comItem 9 Labs Corp.'s Dispensary Brand Strengthens East Coast Footprint with First New Jersey ShopSee More Headlines Receive INLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Item 9 Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2022Today4/25/2024Next Earnings (Estimated)5/20/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Dental equipment & supplies Sub-IndustryN/A Current SymbolOTC:INLB CUSIPN/A CIKN/A Webwww.item9labscorp.com Phone833-867-6337FaxN/AEmployees97Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$21.76 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.65 per share Price / BookN/AMiscellaneous Outstanding Shares701,920,000Free Float562,939,000Market Cap$70,000.00 OptionableNot Optionable Beta0.80 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Robert E. Mikkelsen (Age 42)Secretary, Treasurer & CFO Comp: $263.68kMr. Christopher Leland Wolven (Age 41)Chief Operating Officer Comp: $256.45kMr. Jeffrey I. Rassas (Age 61)Strategic Advisor & Director Comp: $176.58kMs. Jayne LevySenior Vice President of CommunicationsKyle JenningsVice President of MarketingMr. Mark BuschSenior Vice President of Corporate DevelopmentMr. Cory CarterSenior Vice President of CultivationMore ExecutivesKey CompetitorsAdhera TherapeuticsOTCMKTS:ATRXScopus BioPharmaNASDAQ:SCPSGenerex BiotechnologyOTCMKTS:GNBTU.S. Stem CellOTCMKTS:USRMAmarantus BioScienceOTCMKTS:AMBSView All Competitors INLB Stock Analysis - Frequently Asked Questions When is Item 9 Labs' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our INLB earnings forecast. How were Item 9 Labs' earnings last quarter? Item 9 Labs Corp. (OTC:INLB) issued its earnings results on Monday, May, 16th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. How do I buy shares of Item 9 Labs? Shares of INLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTC:INLB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Item 9 Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
